Devin V. McAllister, Ph.D.
Affiliations: | 2000 | Georgia Institute of Technology, Atlanta, GA |
Area:
Chemical Engineering, Biomedical Engineering, Electronics and Electrical EngineeringGoogle:
"Devin McAllister"Parents
Sign in to add mentor| Mark G. Allen | grad student | 2000 | Georgia Tech | |
| (Microfabricated needles for transdermal drug delivery.) | ||||
| Mark R. Prausnitz | grad student | 2000 | Georgia Tech | |
| (Microfabricated needles for transdermal drug delivery.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Adigweme I, Akpalu E, Yisa M, et al. (2022) Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]. Trials. 23: 775 |
| Rouphael NG, Lai L, Tandon S, et al. (2021) Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial. Npj Vaccines. 6: 89 |
| Esser ES, Pulit-Penaloza JA, Kalluri H, et al. (2017) Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring. Scientific Reports. 7: 5705 |
| Rouphael NG, Paine M, Mosley R, et al. (2017) The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet (London, England) |
| Arya J, Henry S, Kalluri H, et al. (2017) Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 128: 1-7 |
| Vassilieva EV, Kalluri H, McAllister D, et al. (2015) Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. Drug Delivery and Translational Research. 5: 360-71 |
| McAllister DV, Wang PM, Davis SP, et al. (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proceedings of the National Academy of Sciences of the United States of America. 100: 13755-60 |
| Kaushik S, Hord AH, Denson DD, et al. (2001) Lack of pain associated with microfabricated microneedles. Anesthesia and Analgesia. 92: 502-4 |
| Matta LM, Nan M, Davis SP, et al. (2001) Miniature excess enthalpy combustor for microscale power generation 39th Aerospace Sciences Meeting and Exhibit |
| McAllister DV, Allen MG, Prausnitz MR. (2000) Microfabricated microneedles for gene and drug delivery. Annual Review of Biomedical Engineering. 2: 289-313 |